PerpEquitiesEquity · Healthcare
Regeneron Pharmaceuticals, Inc. (REGN) perpetual futures
REGN perpetual futures on 6 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade REGNUSDT.
Regeneron Pharmaceuticals is a global biopharmaceutical company developing and marketing treatments for eye, allergic, inflammatory, and other diseases, including EYLEA, Dupixent, and Libtayo.
Price chart
Use the left and right arrow keys to inspect points on the chart.
Trading data
Perpetual market activity
6/6 live markets
Trading data
Perpetual market activity
Spot performance
Venue matrix
6 markets
Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.
| Trade | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 BingX | Trade | REGN-USDT | Trading | $789.46 | -5.5% APR -0.00500% every 8h | +49.0 bps | $1K | $1.2M⚠ | $288.8 | USDT | - | |
 HTX | Trade | REGN/USDT | Trading | $794.10 | - | +190.7 bps | $294.8K | $235.1K | - | USDT | - | |
 Helix (Injective) | Trade | REGN/USDC | Trading | $792.94 | +3.6% APR +0.00042% every 1h | - | - | $40.1K | - | USDC | 12x | |
 Bybit | Trade | REGN/USDT | Trading | $788.63 | 0.0% APR 0.000% every 8h | +48.8 bps | $920.4 | $20.4K | $29.9K | USDT | 25x | |
 Gate.io | Trade | REGN/USDT | Trading | $790.50 | 0.0% APR 0.000% every 8h | +253.3 bps | $0 | $417 | $10.4K | USDT | 20x | |
 Extended | Trade | REGN/USD | Trading | $790.73 | +4.4% APR +0.00050% every 1h | +43.7 bps | $200K | $0 | $0 | USD | 10x |
Tokenized wrappers of the real stock, tradable on-chain and on crypto exchanges around the clock. Premium/discount compares the token price to our stock reference price. Data: CoinMarketCap · Robinhood · DexScreener · GeckoTerminal.
| Product | Price | Premium vs stock | 24h Vol. | Market Cap | Chains |
|---|---|---|---|---|---|
| REGNonOndo GM | $789.81 | -0.54% | $281k | $12k | Solana · Ethereum · BNB Smart Chain (BEP20) |
Tradability
Execution quality
Entry cost and depth per venue at $1k–$100k
Tradability
Execution quality
Entry cost and depth per venue at $1k–$100kThin liquidity · 1 of 6 venues absorb $10k · Typical cost: +29.4 bps
Cheapest execution: Extended · +29.4 bps
Too thin: BingX, Bybit
No fresh book data: HTX, Helix (Injective), Gate.io
Taker execution estimate incl. approx. fees - maker fills are not guaranteed.
Best venues for this underlying
Best liquidity
REGNTightest spread
REGNHighest volume
REGNFunding history
Stored venue snapshots by market
Funding history
Stored venue snapshots by marketCompany data
Company fundamentals
Updated 5h ago
Company data
Company fundamentals
More metrics
Fundamental detail
Annual + quarterlyRefreshed 5h ago
Charts: revenue, profit, cash flow & valuation
Next catalyst
Catalysts
Next catalyst
Catalysts
No unusual perp activity right now.
Research data
Analysts, filings and peer context
Research data
Analysts, filings and peer context
Estimates
6Company events
6Peer comparison
Similar listed perpsRevenue mix
PendingAnalysts
PendingOwnership
REGN-PERPFilings
PendingTranscripts
PendingLatest updates
No recent updates available.FMP company data
Company intelligence
Updated: Sep 14, 2026, 02:13 PM UTC
FMP company data
Company intelligence
Company profile
- Sector
- Healthcare
- Industry
- Biotechnology
- Chief executive
- Leonard S. Schleifer
- Employees
- 15,410
- IPO date
- Apr 2, 1991
- Country
- US
- Exchange
- NASDAQ Global Select
Rating factors
- Return on equityi
- 4
- Return on assetsi
- 5
- Debt to equityi
- 3
- Price to earningsi
- 2
- Price to booki
- 3
Company press releases
Congressional disclosures
Senate
House
Market cap history
Largest fund holders
| Fund | Weight | Shares held |
|---|---|---|
| VTI | 0.11% | 3.3M |
| VOO | 0.12% | 2.6M |
| QQQ | 0.36% | 2.2M |
| IVV | 0.12% | 1.3M |
| FXAIX | 0.12% | 1.2M |
| SPY | 0.12% | 1.2M |
| VO | 0.38% | 1.1M |
| VGHAX | 1.66% | 1M |
| VTV | 0.29% | 981.2K |
| IBB | 5.95% | 768.9K |
| XLV | 1.33% | 721.5K |
| JEPI | 1.06% | 603.5K |
Analyst track record
How the analysts covering REGN have done: ratings, price-target accuracy and the measured reaction after their calls.
| 12 months | 3 years | |
|---|---|---|
| Ratings | 215 | 652 |
| Analysts | 31 | 44 |
| Buy / hold / sell | 150 / 63 / 2 | 510 / 119 / 23 |
| Upgrades / downgrades / initiations | 0 / 3 / 4 | 5 / 9 / 15 |
| Price targets hit / missed | 91 / 115 (44%) | 174 / 432 (29%) |
| Avg. return after a rating (TipRanks) | -1.3% | -9.7% |
| Best / worst call | +46.1% / -25.0% | +57.4% / -39.0% |
After buy calls on this stock: median 21-day move +2.1% vs S&P 500 0.0% (n = 515)
Most accurate on this stock
Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.
- David RisingerLeerink Partners93% hit rate on this stock · 14 targets measuredHoldtarget $824Aug 17, 2026
- Mohit BansalWells Fargo80% hit rate on this stock · 30 targets measuredHoldtarget $750Aug 12, 2026
- Tim AndersonBank of America Securities80% hit rate on this stock · 10 targets measuredSelltarget $627Oct 29, 2025
Latest ratings
| Date | Analyst | Call | Target | |
|---|---|---|---|---|
| Sep 10, 2026 | Brian AbrahamsRBC Capital | HoldMaintained | $737 | article ↗ |
| Sep 10, 2026 | Rajesh KumarHSBC | BuyMaintained | $920 | article ↗ |
| Sep 1, 2026 | Brian AbrahamsRBC Capital | HoldMaintained | $737 | article ↗ |
| Aug 20, 2026 | Louise ChenScotiabank | HoldMaintained | $770 | article ↗ |
| Aug 17, 2026 | Evan SeigermanBMO Capital | BuyMaintained | $800 | article ↗ |
Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.
TipRanks data via FMP · computed Sep 11, 2026 · 215 ratings
Frequently asked questions
Where can I trade REGN perpetual futures?
Regeneron Pharmaceuticals, Inc. (REGN) perpetual futures trade on 6 crypto venues, including BingX, HTX, Helix (Injective). PerpEquities compares them by live price, funding rate, open interest and liquidity.
Can I trade REGN around the clock?
Yes. Unlike the underlying stock, REGN perpetuals trade 24/7 — including weekends and outside regular market hours.
What is the funding rate on REGN perpetuals?
Right now the REGN perp funding rate is 0.0% annualized (venue median), ranging from -5.5% to +4.4% across 6 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.
How does the REGN perp price compare to the Regeneron Pharmaceuticals, Inc. stock?
The venue-median REGN perp mark is $790.6 versus a reference stock price of $794.1, a basis of -0.4%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.
What is a REGN perpetual future?
A REGN perpetual is a derivative that tracks the price of Regeneron Pharmaceuticals, Inc. with no expiry date. It lets you take long or short exposure to Regeneron Pharmaceuticals, Inc. on crypto venues, around the clock.
What is REGNUSDT perpetual?
REGNUSDT is the symbol most crypto exchanges use for the Regeneron Pharmaceuticals, Inc. perpetual settled in USDT (Tether). It tracks the REGN share price through an index, trades 24/7 with leverage and never expires.
Embed this asset
<a href="https://perpequities.com/stocks/regn-perp"><img src="https://perpequities.com/badge/regn-perp.svg" width="240" height="64" alt="REGN perpetuals · perpequities.com" loading="lazy"></a>